STAT3 and breast carcinoma: Using a variety of approaches, including biochemical techniques such as immunoblots and electrophoretic mobility shift assays (EMSAs) as well as immunohistochemistry (IHC), a number of investigators have found evidence of constitutive activation of STAT3 in breast cancer cells but not in normal mammary tissue [11].